Atypical meningiomas are tumors that originate in the meninges and are associated with a high risk of recurrence. Until now, it was unclear whether patients benefit from radiotherapy after complete surgical removal of the tumor. An international study in which MedUni Vienna played a key role provides new evidence that radiotherapy can significantly reduce the recurrence rate. The results, recently published in The Lancet, are set to be incorporated into national and international guidelines.
Radiotherapy Post-Surgery Reduces Recurrence of Atypical Meningiomas, Study Shows
An international study, with significant contributions from MedUni Vienna, has found that radiotherapy after surgery can significantly reduce the recurrence of atypical meningiomas. This finding, published in The Lancet, is expected to influence treatment guidelines globally. The implications for Iran include potential advancements in cancer treatment protocols.
👥 Key Players
📰 What Happened
An international study has shown that radiotherapy after surgery can significantly reduce the recurrence of atypical meningiomas. This finding is expected to change treatment guidelines worldwide.
- Atypical meningiomas have a high risk of recurrence after surgical removal.
- The study's findings will be incorporated into national and international treatment guidelines.
💡 Why It Matters
📚 Background
Atypical meningiomas are tumors that arise from the protective layers of the brain and spinal cord, and their management is crucial due to high recurrence rates.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%